PREDICAGEN LLC REPORT

Size: px
Start display at page:

Download "PREDICAGEN LLC REPORT"

Transcription

1 The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because of several reasons: (a) typically the customer provides limited number of DNA variants since the third party company typically does not do whole DNA sequencing, but rather targets particular positions of the customer DNA; (b) some variants may not be interpretable due to lack of clinical data. In addition, it should be stated again that due to the complexity of human genomic data, the observation that the customer has DNA variant which is found to be disease-causing in another individual does not necessarily indicate that the customer has the same high probability to develop the disease. Finally, due to complexity of matching fussy language expressions, a particular RS may be reported to be associated with more than one disease. PREDICAGEN LLC REPORT Case: 164 Below we describe the meanings of the symbols/abbreviations used in the report. name: Standardized disease names taken in accordance with International Statistical Classifcation of Diseases and Related Health Problems (ICD). This is the name of disease that your primary physician will recognize and use to make decisions about your health. : Corresponding disease names taken from International Statistical Classifcation of Diseases and Related Health Problems (ICD). This is the number (the tag) of disease listed in your primary physician booklet and used by your health insurance provider. score: Disease name matching score using (maximum 100). This is a measure of confidence of matching scientific descriptors and ICD names. The large number(but smaller than 100) indicates high confidence. Phenotype: The set of observable characteristics of corresponding disease. This is scientific description of effect of the DNA variant(s) on functionality of the corresponding biological macromolecules. If you want to know more how your DNA variants affect the corresponding macromolecules functionality at molecular level, you should contact us at support@predicagen.com (mailto: support@predicagen.com). RS : The genetic variants RS. This is a list of DNA variants associated with the corresponding disease. More RS numbers associated with a disease indicate higher probability that you are at risk. High and medium confidence: The first table "high confidence predictions" list cases for which your DNA variant exactly matches the variant in ClinVar database; the second table "medium confidence predictions" list cases for which you do not have the wild type nucleotide. High Confidence Predictions Other disorders of peroxisome biogenesis E Peroxisome biogenesis disorder 6B , Neuronal ceroid lipofuscinosis E Ceroid lipofuscinosis neuronal 1;not Immunodeficiency, un D Immunodeficiency 20;not Primary open-angle glaucoma, left eye, stage un Choroidal dystrophy (central areolar) (generalized) (peripapillary) H Coloboma;Primary open angle glaucoma;not H Choroidal dystrophy, central areolar 2;not /6

2 Beta thalassemia D beta Thalassemia , , Delta-beta thalassemia D delta Thalassemia , Smith-Lemli-Opitz E Smith-Lemli-Opitz ;not Mucopolysaccharidosis, type II E Mucopolysaccharidosis, MPS-III-A , Classical phenylketonuria E Phenylketonuria Tay-Sachs disease E Tay-Sachs disease Other GM2 gangliosidosis E Gm2-gangliosidosis, subacute Refractory anemia, un D Fanconi anemia;not Congenital bullous ichthyosiform erythroderma Q Bullous ichthyosiform erythroderma;not Osteogenesis imperfecta Q Osteogenesis imperfecta type I , Glutaric aciduria type II E Glutaric aciduria, type Metachromatic leukodystrophy E Metachromatic leukodystrophy;not Medium Confidence Predictions Other disorders of peroxisome biogenesis Congenital night blindness E Peroxisome biogenesis disorder 6B H Congenital stationary night blindness , , , , , , /6

3 Folate deficiency anemia, un D Muscle AMP deaminase deficiency;not Ichthyosis vulgaris Q Ichthyosis vulgaris Familial hypercholesterolemia Hyperstimulation of ovaries E Familial hypercholesterolemia N Ovarian hyperstimulation , , MERRF E Perry , , Other hypertrophic cardiomyopathy I Familial hypertrophic cardiomyopathy Other hemochromatosis E Hemochromatosis type Long chain/very long chain acyl CoA dehydrogenase deficiency GM2 gangliosidosis, un Morquio B mucopolysaccharidoses Choroidal dystrophy (central areolar) (generalized) (peripapillary) Disease of pancreas, un Malignant carcinoid tumor of the stomach E Very long chain acyl- CoA dehydrogenase deficiency;not E Infantile GM1 gangliosidosis;not E Mucopolysaccharidosis, MPS-IV-B H Choroidal dystrophy, central areolar 2;not K Parkinson disease 2;not C7A Malignant tumor of prostate , , , , , , , Achromatopsia H Achromatopsia /6

4 Non-ketotic hyperglycinemia Familial dysautonomia [Riley-Day] Hemophagocytic lymphohistiocytosis E Non-ketotic hyperglycinemia G Familial dysautonomia;not D Hemophagocytic lymphohistiocytosis, familial, , Beta thalassemia D beta Thalassemia , , Neuronal ceroid lipofuscinosis Transient neonatal myasthenia gravis E Ceroid lipofuscinosis neuronal 2 P Cyanosis, transient neonatal Delta-beta thalassemia D delta Thalassemia , , , Congenital central alveolar hypoventilation Smith-Lemli-Opitz Aggressive periodontitis, un G Congenital central hypoventilation E Smith-Lemli-Opitz K Periodontitis, aggressive, , , Dystonia, un G Dystonia;not Hereditary vitamin D- dependent rickets (type 1) (type 2) Congenital bullous ichthyosiform erythroderma E Vitamin D-dependent rickets, type 1 Q Bullous ichthyosiform erythroderma;not , , , , , , Classical phenylketonuria E Phenylketonuria Wilson's disease E Wilson disease /6

5 Other viral diseases Obstructive hypertrophic cardiomyopathy Alpha-1-antitrypsin deficiency Keratosis punctata (palmaris et plantaris) Other GM2 gangliosidosis B Wilson disease;not I Hypertrophic cardiomyopathy;not E Alpha-1-antitrypsin deficiency L Keratosis palmoplantaris papulosa E Gm2-gangliosidosis, late onset , Medullary cystic kidney Q Medullary cystic kidney disease Macular corneal dystrophy Osteogenesis imperfecta Niemann-Pick disease type C 3-methylglutaconic aciduria H Macular corneal dystrophy Type I Q Osteogenesis imperfecta type I E Niemann-Pick disease type C1 E Methylglutaconic aciduria type , , , , , , , , , , , , , , , , , , , Dressler's I Kindler's , Hermansky-Pudlak Metachromatic leukodystrophy E Hermansky-Pudlak 4 E Metachromatic leukodystrophy, adult type /6

6 Print this page 2014 Predicagen, LLC. 6/6

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function 1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency

More information

ICD-10 Physician Education. Medical Genetics

ICD-10 Physician Education. Medical Genetics ICD-10 Physician Education Medical Genetics Training Objectives ICD-9 to ICD-10 Comparison Documentation Tips Additional Educational Opportunities Questions 2 ICD-9 to ICD-10 Comparison Code Structure

More information

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS ACQUIRED ANEMIAS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type)

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type) Blood and Clotting Coagulation factor VII deficiency Elliptocytosis Hemophilia A (German Shepherd Dog, type 2) Pyruvate kinase deficiency (Labrador Retriever type) Thrombopathia (American Eskimo Dog type)

More information

Standard Therapies - Cord Blood

Standard Therapies - Cord Blood A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical

More information

Subject: Enteral Formulas

Subject: Enteral Formulas 09-J0000-61 Original Effective Date: 07/15/02 Reviewed: 04/26/18 Revised: 11/15/18 Subject: Enteral Formulas THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION OF BENEFITS,

More information

Family Medical History Questionnaire (FMHQ)

Family Medical History Questionnaire (FMHQ) First, Last Name DOB: Cord Blood Bank Use Only: Family Medical History Questionnaire (FMHQ) NMDP CBU ID: Local CBU ID: NMDP Maternal ID: Today's Date: Local Maternal ID: Baby's Mother's Initials: Please

More information

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A. Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 6 PURPOSE To establish basic understanding of indications and contraindications for transplantation of various organs. POLICY The N.C. Department of Correction, Division of Prisons, Health Services

More information

Results for Trendy. Explanation of Results

Results for Trendy. Explanation of Results Canine HealthCheck Results for Trendy Trendy's genetic health profile: Trendy's appearance profile: Trendy is not at-risk for any of the diseases tested Trendy is a Female Trendy is not a carrier for any

More information

Should Universal Carrier Screening be Universal?

Should Universal Carrier Screening be Universal? Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

Results for Diva. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Diva. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Diva Diva's demographic profile: Call Name: Diva Registered Name: Rus Pekos Diva Chudo Prirody Breed: Golden Retriever Sex: Female Approx. DOB: 2016-07 Owner: Registration

More information

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

Clinical Approach to Diagnosis of Lysosomal Storage Diseases Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders

More information

Results for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Dar Dar's demographic profile: Call Name: Dar Registered Name: Newman's Allendar of Lost Acres Breed: Collie Sex: Male Age: 0 Owner: Registration #: DN47650805 Microchip/Tattoo:

More information

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL

More information

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Farrah Farrah's demographic profile: Call Name: Farrah Registered Name: Amber Bear's She's All That Breed: Collie Sex: Female Age: 1 Owner: Registration #: DN44645703 Microchip/Tattoo:

More information

Genetic Diseases. SCPA202: Basic Pathology

Genetic Diseases. SCPA202: Basic Pathology Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities

More information

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Allogeneic Hematopoietic Transplant for Genetic Diseases and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allogeneic_hematopoietic_transplant_for_genetic_diseases

More information

Results for Ceaser. Em Locus (Melanistic Mask) Explanation of Results

Results for Ceaser. Em Locus (Melanistic Mask) Explanation of Results Results for Ceaser Ceaser's demographic profile:!"## $"%&'!&"(&) *&+,(-&)&. $"%&' /000000 1)&&.' 12##.3+ /&0' 4"#& 566)307 891' :;;?!"#$%&'''''''!"#$%&'(&$)* +, -./4567 0$1')12$345(&&)),!"# $% &'&((((

More information

Pet Profile Number: Date of Test: 02/19/2009 Date of Certificate: 09/16/2009 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Co

Pet Profile Number: Date of Test: 02/19/2009 Date of Certificate: 09/16/2009 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Co Pet Profile Number: Date of Test: 02/19/2009 Date of Certificate: 09/16/2009 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Coat Color: Eye Color: Weight: Microchip: Microchip Type:

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is administered by the Illinois Department of Public Health.

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) (Formerly Genetic Testing for Inherited Disorders) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization Yes Review Dates:

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

Pet Profile Number: Date of Test: 00/00/0000 Date of Certificate: 00/00/0000 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Co

Pet Profile Number: Date of Test: 00/00/0000 Date of Certificate: 00/00/0000 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Co Pet Profile Number: Date of Test: 00/00/0000 Date of Certificate: 00/00/0000 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Coat Color: Eye Color: Weight: Microchip: Microchip Type:

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Rare Disease Day Brussels, 1 March

Rare Disease Day Brussels, 1 March Research activities in Europe: Trends and determinants Rare Disease Day Brussels, 1 March 2010 Research Death valley Development Collaboration clinicians / researchers Pharmaceutical Innovation / Performance

More information

Phosphorus. Diagnostics

Phosphorus. Diagnostics 14 32 6 32 Phosphorus Diagnostics 7 Genomics, illuminated. We focus on your peace of mind. Our expert-guided assay designs, powerful data analytics, and rigorous variant interpretation ensure accurate

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995 RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE

More information

Hereditary disorders of peroxisomal metabolism.

Hereditary disorders of peroxisomal metabolism. Hereditary disorders of peroxisomal metabolism http://www.cytochemistry.net/cell-biology/perox.jpg Peroxisomes single membrane organelles from less than 100 to more than 1000 per eucaryotic cell more than

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

PATIENT EDUCATION. carrier screening INFORMATION

PATIENT EDUCATION. carrier screening INFORMATION PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Carrier Screening for Genetic Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carrier_screening_for_genetic_disease 12/2013 7/2017 7/2018 7/2017

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN Genomics and Genetics in Healthcare By Mary Knutson, RN, MSN Clinical Objectives Understand the importance of genomics to provide effective nursing care Integrate genetic knowledge and skills into nursing

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry)

STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry) STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry) 1 1 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml 1 Patient 1 RELAPSED BILINEAGE LEUKEMIA HLA match

More information

Expanded Carrier Screening: What s Best?

Expanded Carrier Screening: What s Best? Expanded Carrier Screening: What s Best? James D Goldberg, MD September 17, 2017 Disclosures James D. Goldberg, M.D. Chief Medical Officer, Counsyl 3 Learning Objectives Guidelines Data Design Practice

More information

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome Report Date: August 2, 215 Software Annotation Version: 8 Genome Summary Name: Greg Mendel Genome ID: genome_greg_mendel_dad Sequencing Provider: 23andMe Sequencing Type: Genotyping SNP Array Sequencing

More information

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission

More information

Archived Reports Summary

Archived Reports Summary Archived Reports Summary 1 Archived Reports Summary This summary provides information that may be helpful when viewing your archived reports. The information in this document and in your reports is intended

More information

Related Policies None

Related Policies None Medical Policy MP 2.04.107 BCBSA Ref. Policy: 2.04.107 Last Review: 04/30/2018 Effective Date: 04/30/0218 Section: Medicine Related Policies None DISCLAIMER Our medical policies are designed for informational

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

The role of the laboratory in diagnosing lysosomal disorders

The role of the laboratory in diagnosing lysosomal disorders The role of the laboratory in diagnosing lysosomal disorders Dr Guy Besley, formerly Willink Biochemical Genetics Unit, Manchester Children s Hospital, Manchester M27 4HA, UK. Lysosomal disorders What

More information

DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013

DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013 DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History Tuesday, April 16, 2013 Objectives Recognize the importance & impact of newborn screening Describe the process of newborn screening

More information

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Carrier Screening and Diagnostic Testing for the Ashkenazi Jewish Population Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Our Science. Your Care. An extensive

More information

Approach to diagnosis of metabolic diseases

Approach to diagnosis of metabolic diseases Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

Sample page. Laboratory. Cross Coder. Essential links from CPT codes to ICD-10-CM and HCPCS

Sample page. Laboratory. Cross Coder. Essential links from CPT codes to ICD-10-CM and HCPCS Cross Coder 2018 Laboratory Essential links from CPT codes to ICD-10-CM and HCPCS POWER UP YOUR CODING with Optum360, your trusted coding partner for 32 years. Visit optum360coding.com. Contents Introduction...i

More information

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016. CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to

More information

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl Formal Genetics of Humans: Modes of Inheritance Dr. S Hosseini-Asl 1 Autosomal dominant (AD) a: Wild type (Wt) allele A: Mutant allele aa: Normal phenotype Aa: Affected (heterozygous) AA: Affected (homozygous)

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

Pet Profile Number: Date of Test: 02/19/2009 Date of Certificate: 09/16/2009 Canine Pet Name: Date of Birth: Pet Type: Breed: Sex: Spayed/Neutered: Coat Color: Eye Color: Weight: Microchip: Microchip Type:

More information

Aid to the MRCP PACES Volume 1 - Stations 1, 3 and 5,

Aid to the MRCP PACES Volume 1 - Stations 1, 3 and 5, Aid to the MRCP PACES Volume 1 - Stations 1, 3 and 5, Ryder ISBN-13: 9780470655092 Table of Contents Preface Preface to the third edition Preface to the second edition Preface to the first edition Introduction

More information

Genetic screening. Martin Delatycki

Genetic screening. Martin Delatycki 7 Genetic screening Martin Delatycki Case study 1 Vanessa and John are planning a family. They see their general practitioner and ask whether they should have any tests prior to falling pregnant to maximise

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

List of Qualifying Conditions

List of Qualifying Conditions List of Qualifying Conditions Cancer Conditions 1) Adrenal cancer 2) Bladder cancer 3) Bone cancer all forms 4) Brain cancer 5) Breast cancer 6) Cervical cancer 7) Colon cancer 8) Colorectal cancer 9)

More information

Survey of prenatal testing for genetic disorders in Japan: Recent report

Survey of prenatal testing for genetic disorders in Japan: Recent report doi:10.1111/jog.12948 J. Obstet. Gynaecol. Res. Vol. 42, No. 4: 375 379, April 2016 Survey of prenatal testing for genetic disorders in Japan: Recent report Takahiro Nobuzane 1, Takahiro Yamada 2,KiyonoriMiura

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

Hereditary disorders of peroxisomal metabolism.

Hereditary disorders of peroxisomal metabolism. Hereditary disorders of peroxisomal metabolism http://www.cytochemistry.net/cell-biology/perox.jpg Peroxisomes single membrane organelles from less than 100 to more than 1000 per eukaryotic cell more than

More information

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Policy Number: Original Effective Date: MM.07.001 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO

More information

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No

More information

Mississippi Newborn Screening Report

Mississippi Newborn Screening Report Mississippi Newborn Screening Report 2011-2016 Introduction The primary goal of the Newborn Screening Program is to screen every infant born in the state and refer infants with abnormal results to appropriate

More information

Redefining HIV encephalopathy in children living in SSA

Redefining HIV encephalopathy in children living in SSA Redefining HIV encephalopathy in children living in SSA Charles RJC Newton Kenya Medical Research Institute/ Wellcome Trust Collaborative Programme, Kilifi, Kenya Epidemiology of HIV in Children living

More information

Genetic Testing for Non-Cancerous Inheritable Diseases

Genetic Testing for Non-Cancerous Inheritable Diseases Genetic Testing for Non-Cancerous Inheritable Diseases Policy Number: Original Effective Date: MM.02.009 03/01/2010 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2016 Section:

More information

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017 Large-scale identity-by-descent mapping discovers rare haplotypes of large effect Suyash Shringarpure 23andMe, Inc. ASHG 2017 1 Why care about rare variants of large effect? Months from randomization 2

More information

Spring Course Schedule Template 2007 Hour Monday Tuesday Wednesday Thursday Friday. 1:00-1:30 PM Biochemistry Biochemistry Biochemistry Biochemistry

Spring Course Schedule Template 2007 Hour Monday Tuesday Wednesday Thursday Friday. 1:00-1:30 PM Biochemistry Biochemistry Biochemistry Biochemistry Spring Course Schedule Template 2007 Hour Monday Tuesday Wednesday Thursday Friday 1:00-1:30 Biochemistry Biochemistry Biochemistry Biochemistry Biochem./Physio. Quiz 1:30-2:00 Lecture Lecture Lecture

More information

Natural History of JNCL and other NCLs

Natural History of JNCL and other NCLs Natural History of JNCL and other NCLs Jonathan W. Mink, MD PhD Departments of Neurology, Neurobiology & Anatomy, Brain & Cognitive Sciences, and Pediatrics University of Rochester Neuronal Ceroid Lipofuscinosis

More information

Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD. Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No

Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD. Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No Legal County (DHS Child) Resident County (Non-DHS Child)

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

KNOWING YOUR FAMILY HEALTH HISTORY COULD SAVE YOUR LIFE!

KNOWING YOUR FAMILY HEALTH HISTORY COULD SAVE YOUR LIFE! KNOWING YOUR FAMILY HEALTH HISTORY COULD SAVE YOUR LIFE! Why is my family health history so important? Several important reasons to know your family health history! Because some conditions run in families

More information

ICD- 9 to ICD- 10 Transition PT SERVICES. October 1, 2015

ICD- 9 to ICD- 10 Transition PT SERVICES. October 1, 2015 ICD- 9 to ICD- 10 Transition PT SERVICES October 1, 2015 ICD- 9 ICD- 10 Description (ICD- 10) 1919 C71.9 Malignant neoplasm of brain, unspecified 1940 C74.90 Malignant neoplasm of unspecified part of unspecified

More information

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)

More information

Genomics in Primary Care: The Promise of Personalized Medicine

Genomics in Primary Care: The Promise of Personalized Medicine Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Genomics in Primary Care: The Promise of Personalized Medicine Heather B. Fagan MD, MPH Brian Stello MD Lehigh Valley Health

More information

Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012

Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012 MEDICAL POLICY Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012 Title Allogeneic Hematopoietic Stem Cell Transplantation for Genetic Diseases and Acquired Description Hematopoietic

More information

Notifiable Medical Conditions

Notifiable Medical Conditions Notifiable Medical Conditions A Acoustic neuroma Addison s disease Agoraphobia AIDS Alcohol problems Alzheimer s disease Amyotrophic Lateral Sclerosis - see Motor Neurone Disease Amputations Aneurysm Angina

More information

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012. January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding

More information

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to

More information

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. EVOLVE CARRIER GENETIC SCREENS Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. PROTECT THE HEALTH OF YOUR FUTURE CHILDREN BY KNOWING YOUR GENETIC RISKS, TODAY! Carrier

More information